Humanigen (HGEN) News Today → What President Biden's new law means for investors (From Stansberry Research) (Ad) Free HGEN Stock Alerts $0.0002 0.00 (0.00%) (As of 05/20/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 24, 2024 | finance.yahoo.comHumanigen Inc (0KB2.BE)February 6, 2024 | morningstar.comHumanigen Inc HGENQJanuary 25, 2024 | markets.businessinsider.comLevi & Korsinsky, LLP Notifies Shareholders of Humanigen, Inc. (HGEN) an Upcoming Claims Deadline in a Class Action SettlementJanuary 17, 2024 | wsj.comFirm Retention Summary: HumanigenJanuary 5, 2024 | msn.comHumanigen Downfall: FDA Rejection For COVID-19 Drug Triggers Financial Crisis, BankruptcyJanuary 4, 2024 | news.yahoo.comCOVID-19 treatment developer Humanigen files for Chapter 11 bankruptcyJanuary 4, 2024 | wsj.comCovid-19 Treatment Developer Humanigen Files for BankruptcyJanuary 4, 2024 | msn.comCOVID pick Humanigen files for bankruptcyDecember 9, 2023 | finanznachrichten.deAktueller Chart HUMANIGEN AktieOctober 13, 2023 | uk.finance.yahoo.comHumanigen, Inc. (HGEN) stock historical prices & data – Yahoo FinanceAugust 11, 2023 | uk.finance.yahoo.comHumanigen, Inc. (HGEN) stock price, news, quote & history – Yahoo FinanceAugust 7, 2023 | finance.yahoo.comHumanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell TransplantationJuly 30, 2023 | proactiveinvestors.comHumanigen stock removed from S&P Total Market Index as firm faces...July 28, 2023 | proactiveinvestors.comHumanigen stock removed from S&P Total Market Index as firm faces bankruptcyJuly 25, 2023 | marketwatch.comHumanigen Shares Plunge 73% as Business Combination Fails, Going Concern Issues RaisedJuly 25, 2023 | markets.businessinsider.comWhy Is Humanigen (HGEN) Stock Down 72% Today?July 25, 2023 | msn.comHumanigen (NASDAQ:HGEN) Nosedives with Bankruptcy Looming LargeJuly 25, 2023 | seekingalpha.comHumanigen to weigh bankruptcy as shares delist from NasdaqApril 17, 2023 | nasdaq.comHumanigen (HGEN) Surges on Lenzilumab Study Data for LeukemiaApril 14, 2023 | finance.yahoo.comHumanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of LeukemiaDecember 20, 2022 | finance.yahoo.comHumanigen, Inc. (HGEN) Stock Historical Prices & Data - Yahoo FinanceNovember 14, 2022 | finance.yahoo.comHumanigen Reports Third Quarter 2022 Financial ResultsNovember 10, 2022 | finance.yahoo.comHumanigen Announces Participation and Presentation at Jefferies London Healthcare ConferenceOctober 31, 2022 | finance.yahoo.comHumanigen Announces Retention of SC&H Capital as Financial AdvisorOctober 19, 2022 | stockhouse.com2022-10-19 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 19, 2022 | benzinga.comThis Addiction Drug Shows Some Potential Against Long COVID Symptoms - Humanigen (NASDAQ:HGEN), GSK (NYSE - BenzingaOctober 19, 2022 | benzinga.comCLASS ACTION UPDATE for HGEN, SQ and OPEN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Be - BenzingaOctober 18, 2022 | businesswire.comGLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Humanigen, Inc. Investors to Secure Counsel Before Important October 25 Deadline in Securities Class Action – HGEN - Business WireOctober 18, 2022 | prnewswire.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important October 25 Deadline in Securities Class Action - HGENOctober 17, 2022 | gurufocus.comBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Coupang, Humanigen, Latch, and Azure and Encourages Investors to Contact the Firm - GuruFocus.comOctober 16, 2022 | benzinga.comHGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Humanigen, Inc. Investors of a Class Action Lawsuit and Upc - BenzingaOctober 15, 2022 | stockhouse.com2022-10-15 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 14, 2022 | gurufocus.comHGEN SHAREHOLDER ALERT: Jakubo - GuruFocus.comOctober 14, 2022 | stockhouse.com2022-10-14 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 13, 2022 | gurufocus.comHGEN LAWSUIT ALERT: Levi & Kor - GuruFocus.comOctober 13, 2022 | benzinga.comROSEN, RESPECTED INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors With Losses to Secure Counsel Bef - BenzingaOctober 13, 2022 | stockhouse.com2022-10-13 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 12, 2022 | benzinga.comHumanigen Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 25, 2022 - BenzingaOctober 11, 2022 | benzinga.comBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Coupang, - BenzingaOctober 10, 2022 | stockhouse.com2022-10-09 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 10, 2022 | benzinga.comROSEN, NATIONAL TRIAL LAWYERS, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important De - BenzingaOctober 8, 2022 | prnewswire.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN - PR NewswireOctober 8, 2022 | prnewswire.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGENOctober 7, 2022 | reuters.comHGEN.N - Humanigen Inc | Stock Price & Latest News | ReutersOctober 7, 2022 | stockhouse.com2022-10-06 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 6, 2022 | benzinga.comBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch F - BenzingaOctober 6, 2022 | benzinga.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Humanigen, - BenzingaOctober 5, 2022 | stockhouse.com2022-10-05 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 4, 2022 | benzinga.comCLASS ACTION UPDATE for CPNG, HGEN and SMFR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on - BenzingaOctober 4, 2022 | prnewswire.comThinking about buying stock in Connect Biopharma, Rivian Automotive, AeroClean Technologies, Kiora Pharmaceuticals, or Humanigen? - PR Newswire Get Humanigen News Delivered to You Automatically Sign up to receive the latest news and ratings for HGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. HGEN Media Mentions By Week HGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HGEN News Sentiment▼0.000.42▲Average Medical News Sentiment HGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HGEN Articles This Week▼00▲HGEN Articles Average Week Get Humanigen News Delivered to You Automatically Sign up to receive the latest news and ratings for HGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bruush Oral Care News Statera Biopharma News Minerva Surgical News Kaleido Biosciences News Alpha Tau Medical News Artelo Biosciences News BriaCell Therapeutics News eFFECTOR Therapeutics News Fortress Biotech News GeoVax Labs News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HGEN) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaThe #1 Crypto for AIWeiss RatingsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestElon to Transform U.S. Economy? Porter & Company Former CIA advisor: Dark side of AI now startingParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humanigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
